相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Martin Guilliams et al.
CELL (2022)
Liver zonation, revisited
Jasmin Paris et al.
HEPATOLOGY (2022)
The Role of Liver Zonation in Physiology, Regeneration, and Disease
Regeant Panday et al.
SEMINARS IN LIVER DISEASE (2022)
βIII-Tubulin Gene Regulation in Health and Disease
Alastair M. P. Duly et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Untangling the roles of TOP2A and TOP2B in transcription and cancer
Liis Uuskula-Reimand et al.
SCIENCE ADVANCES (2022)
Polo-like kinase 1 (PLK1) signaling in cancer and beyond
Styliani Iliaki et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Inhibiting homologous recombination by targeting RAD51 protein
A. Demeyer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
BIRC3 and BIRC5: multi-faceted inhibitors in cancer
Raffaele Frazzi
CELL AND BIOSCIENCE (2021)
Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance
Isabel Garcia-Saez et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Liver zonation
Rita Manco et al.
JOURNAL OF HEPATOLOGY (2021)
Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Xiaoyang Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer
Naheed Arfin Borah et al.
MOLECULES (2021)
Future prospects for mitosis-targeted antitumor therapies
Alfonso Serrano-del Valle et al.
BIOCHEMICAL PHARMACOLOGY (2021)
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
Danielle Maeser et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Metabolism-associated molecular classification of hepatocellular carcinoma
Chen Yang et al.
MOLECULAR ONCOLOGY (2020)
Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis
Prakash Ramachandran et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
Zhong-Zhe Lin et al.
ONCOLOGIST (2020)
Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells
Dusana Majera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment
Guya Diletta Marconi et al.
MOLECULES (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Spatial sorting enables comprehensive characterization of liver zonation
Shani Ben-Moshe et al.
NATURE METABOLISM (2019)
Axitinib in metastatic renal cell carcinoma: beyond the second-line setting
Yoshiko Umeyama et al.
FUTURE ONCOLOGY (2017)
Human Hepatocellular Carcinomas With a Periportal Phenotype Have the Lowest Potential for Early Recurrence After Curative Resection
Romain Desert et al.
HEPATOLOGY (2017)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
Keren Bahar Halpern et al.
NATURE (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor
Cameron T. Durlacher et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells
Francesca De Iuliis et al.
INVESTIGATIONAL NEW DRUGS (2016)
Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
Yuan Tian et al.
CANCERS (2016)
Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma
Y. -K. Kang et al.
ANNALS OF ONCOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma
Hongping Xia et al.
ONCOTARGET (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Liver zonation: Novel aspects of its regulation and its impact on homeostasis
Rolf Gebhardt et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas
Wenqing Qi et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?
Clara L. Freeman et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Update on aurora kinase targeted therapeutics in oncology
Myke R. Green et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease
Naga Chalasani et al.
JOURNAL OF HEPATOLOGY (2008)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
分享论文
